Vericiguat en insuficiencia cardíaca: de la evidencia científica a la práctica clínica
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vericiguat en insuficiencia cardíaca: de la evidencia científica a la práctica clínica
Authors
Keywords
cGMP, Heart failure, Nitric oxide, Vericiguat
Journal
REVISTA CLINICA ESPANOLA
Volume 222, Issue 6, Pages 359-369
Publisher
Elsevier BV
Online
2022-02-25
DOI
10.1016/j.rce.2021.12.005
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Soluble guanylate cyclase stimulators and their potential use: a patent review
- (2021) Peter Sandner et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction
- (2021) Thomas M. Maddox et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018
- (2021) Giosafat Spitaleri et al. Scientific Reports
- Budget Impact Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Event
- (2021) Adnan Alsumali et al. ADVANCES IN THERAPY
- CCS/CHFS Heart Failure Guidelines Update: Defining a New Pharmacologic Standard of Care for Heart Failure With Reduced Ejection Fraction
- (2021) Michael McDonald et al. CANADIAN JOURNAL OF CARDIOLOGY
- Patients profiling in Heart Failure for tailoring medical therapy A consensus document of the Heart Failure Association of the European Society of Cardiology
- (2021) Giuseppe M.C. Rosano et al. EUROPEAN JOURNAL OF HEART FAILURE
- Renal Function and the Effects of Vericiguat in Patients with Worsening Heart Failure with Reduced Ejection Fraction: Insights from VICTORIA ( VerICiguaT Global Study in Subjects with HFrEF ) Trial
- (2021) Adriaan A. Voors et al. EUROPEAN JOURNAL OF HEART FAILURE
- Population Pharmacokinetics and Pharmacodynamics of Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
- (2021) Hauke Ruehs et al. CLINICAL PHARMACOKINETICS
- 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2021) Theresa A McDonagh et al. EUROPEAN HEART JOURNAL
- Consulta electrónica (e-consulta) para pacientes con insuficiencia cardiaca. Resultados a largo plazo
- (2021) Sergio Cinza Sanjurjo et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association
- (2020) Salim S. Virani et al. CIRCULATION
- Comparing the Benefit Of Novel Therapies Across Clinical Trials: Insights from the VICTORIA Trial
- (2020) Javed Butler et al. CIRCULATION
- Metabolism and Pharmacokinetic Drug–Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies
- (2020) Michael Boettcher et al. CLINICAL PHARMACOKINETICS
- Evaluation of high-sensitivity C-reactive protein and uric acid in vericiguat-treated patients with heart failure with reduced ejection fraction
- (2020) Frank Kramer et al. EUROPEAN JOURNAL OF HEART FAILURE
- Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials
- (2020) Muthiah Vaduganathan et al. LANCET
- Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
- (2020) Paul W. Armstrong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insuficiencia cardiaca y medicina basada en la evidencia: no todo está en las guías
- (2020) Manuel Anguita REVISTA ESPANOLA DE CARDIOLOGIA
- Epidemiology of heart failure
- (2020) Amy Groenewegen et al. EUROPEAN JOURNAL OF HEART FAILURE
- 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
- (2020) Sandeep R. Das et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Insuficiencia cardiaca de novo tras un síndrome coronario agudo en pacientes sin insuficiencia cardiaca ni disfunción ventricular izquierda
- (2020) Alberto Cordero et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Costs and healthcare utilisation of patients with heart failure in Spain
- (2020) Carlos Escobar et al. BMC HEALTH SERVICES RESEARCH
- Relative Efficacy of Sacubitril-Valsartan, Vericiguat, and SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: a Systematic Review and Network Meta-Analysis
- (2020) Alberto Aimo et al. CARDIOVASCULAR DRUGS AND THERAPY
- Pharmacodynamic and Pharmacokinetic Interaction Profile of Vericiguat: Results from Three Randomized Phase I Studies in Healthy Volunteers
- (2020) Michael Boettcher et al. CLINICAL PHARMACOKINETICS
- Ten lessons from the EMPEROR‐Reduced trial
- (2020) Javed Butler et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction
- (2020) Paul W. Armstrong et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction
- (2020) James E. Udelson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- How Should We Sequence the Treatments for Heart Failure and a Reduced Ejection Fraction? A Redefinition of Evidence-Based Medicine
- (2020) John J.V. McMurray et al. CIRCULATION
- Clinical Outcomes and Response to Vericiguat According to Index Heart Failure Event
- (2020) Carolyn S. P. Lam et al. JAMA Cardiology
- Epidemiología y tratamiento de la insuficiencia cardiaca en España: estudio PATHWAYS-HF
- (2020) Antoni Sicras-Mainar et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Clinical Course of Patients With Worsening Heart Failure With Reduced Ejection Fraction
- (2019) Javed Butler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Discharge treatment with ACE inhibitor/ARB after a heart failure hospitalization is associated with a better prognosis irrespectively of left ventricular ejection fraction
- (2019) Lourdes Vicent et al. INTERNAL MEDICINE JOURNAL
- Significant and constant increase in hospitalization due to heart failure in Spain over 15 year period
- (2019) Manuel Méndez-Bailón et al. European Journal of Internal Medicine
- Rationale and Design of the VITALITY-HFpEF Trial
- (2019) Javed Butler et al. Circulation-Heart Failure
- Short term prognosis of heart failure after first hospital admission
- (2019) Joan Masip et al. MEDICINA CLINICA
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of sodium glucose cotransporter 2 inhibitors on cardiac function and cardiovascular outcome: a systematic review
- (2019) Koichiro Matsumura et al. Cardiovascular Ultrasound
- Cambio en la causa de muerte e influencia de la mejora terapéutica con el tiempo en pacientes con insuficiencia cardiaca y fracción de eyección reducida
- (2019) David Fernández-Vázquez et al. REVISTA ESPANOLA DE CARDIOLOGIA
- Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry
- (2019) Mitja Lainščak et al. EUROPEAN JOURNAL OF HEART FAILURE
- Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial
- (2019) Burkert Pieske et al. EUROPEAN JOURNAL OF HEART FAILURE
- From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators
- (2018) Peter Sandner BIOLOGICAL CHEMISTRY
- Cost-of-illness studies in heart failure: a systematic review 2004–2016
- (2018) Wladimir Lesyuk et al. BMC Cardiovascular Disorders
- A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of the Oral Soluble Guanylate Cyclase Stimulator
- (2018) Paul W. Armstrong et al. JACC-Heart Failure
- Outpatient Worsening Heart Failure as a Target for Therapy
- (2018) Stephen J. Greene et al. JAMA Cardiology
- Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
- (2017) Burkert Pieske et al. EUROPEAN HEART JOURNAL
- Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study
- (2017) Gerasimos Filippatos et al. EUROPEAN JOURNAL OF HEART FAILURE
- Systematic review of economic burden of heart failure
- (2017) Asrul Akmal Shafie et al. HEART FAILURE REVIEWS
- Trends in comorbidity in patients hospitalised for cardiovascular disease
- (2017) Josefien Buddeke et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure
- (2017) Markus Follmann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
- (2016) Piotr Ponikowski et al. EUROPEAN HEART JOURNAL
- The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database
- (2016) Aldo P. Maggioni et al. EUROPEAN JOURNAL OF HEART FAILURE
- Comparison of Risk of Re-hospitalization, All-Cause Mortality, and Medical Care Resource Utilization in Patients With Heart Failure and Preserved Versus Reduced Ejection Fraction
- (2015) Gregory A. Nichols et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction
- (2015) Mihai Gheorghiade et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)
- (2014) Diana Bonderman et al. CHEST
- Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES)
- (2014) Burkert Pieske et al. EUROPEAN JOURNAL OF HEART FAILURE
- Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
- (2014) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Soluble guanylate cyclase: a potential therapeutic target for heart failure
- (2012) Mihai Gheorghiade et al. HEART FAILURE REVIEWS
- Rehospitalization for Heart Failure
- (2012) Mihai Gheorghiade et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Sympathetic Nervous System in Heart Failure
- (2009) Filippos Triposkiadis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More